Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
biogen
biomarin pharmaceutical
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
2
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
ipo
2
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
2
×
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
vc
2
×
venture capital
wisconsin blog main
wisconsin top stories
accent therapeutics
administration
aducanumab
alzheimer's
alzheimer's disease
amblyotech
What
bio
roundup
activity
approvals
becker
billions
biogen
clamped
covid
delays
developing
dollars
eaton
economic
fast
fda
gene
healthcare
impact
including
ipo
isn’t
life
lot
medicines
michael
millions
moves
new
oric’s
patients
science
showing
spread
suzanne
talk
terms
testing
therapy
vast
Language
unset
Current search:
ipo
×
vc
×
" new york top stories "
×
photo
×
cancer
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More